These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7353752)

  • 21. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatic encephalopathies; hemodynamic and metabolic study of the influence of ammonia and levodopa].
    Baldy-Moulinier M; Bories P; Michel H; Passouant P
    Rev Neurol (Paris); 1977 Mar; 133(3):175-89. PubMed ID: 918461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of chronic portasystemic encephalopathy with bromocryptine].
    Ubiria J; Morales M; Vila A; Farre A; Balanzo J
    Rev Esp Enferm Apar Dig; 1980 Jul; 58(1):21-4. PubMed ID: 7403629
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chronic hepatic encephalopathy with levodopa.
    Lunzer M; James IM; Weinman J; Sherlock S
    Gut; 1974 Jul; 15(7):555-61. PubMed ID: 4430473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.
    Ahl B; Weissenborn K; van den Hoff J; Fischer-Wasels D; Köstler H; Hecker H; Burchert W
    Hepatology; 2004 Jul; 40(1):73-9. PubMed ID: 15239088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of neuropsychological testing and electroencephalogram for early detection of minimal hepatic encephalopathy].
    Choi CS; Kim BI; Lee MH; Choi HS; Kim SH; Ahn DH
    Korean J Hepatol; 2005 Dec; 11(4):329-38. PubMed ID: 16380662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Essential phospholipids in the treatment of hepatic encephalopathy].
    Brůha R; Marecek Z
    Vnitr Lek; 2000 Apr; 46(4):199-204. PubMed ID: 11227171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral blood flow in basal ganglia is correlated with clinical signs of hepatic encephalopathy in patients with liver cirrhosis.
    Iwasa M; Kaito M; Adachi Y; Watanabe Y; Matsumura K; Takeda K
    Am J Gastroenterol; 2002 Mar; 97(3):763-4. PubMed ID: 11922581
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
    Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
    Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Bolton RP; Losowsky MS
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():66-73. PubMed ID: 2083938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of regional cerebral metabolism in patients with cirrhosis in positron emission tomography.
    Ikeda K; Tsuji H; Azuma K; Hashiguchi M; Ogata H; Ibayashi S; Fujishima M; Iida M; Ichiya Y
    Fukuoka Igaku Zasshi; 2001 Aug; 92(8):306-14. PubMed ID: 11586515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auditory event-related cerebral potentials (P300) in hepatic encephalopathy--topographic distribution and correlation with clinical and psychometric assessment.
    Hollerbach S; Kullmann F; Fründ R; Lock G; Geissler A; Schölmerich J; Holstege A
    Hepatogastroenterology; 1997; 44(16):1002-12. PubMed ID: 9261590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatic coma].
    Walter E
    Schweiz Med Wochenschr; 1994 Jul; 124(26):1147-54. PubMed ID: 7914030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study.
    Aggarwal S; Kramer D; Yonas H; Obrist W; Kang Y; Martin M; Policare R
    Hepatology; 1994 Jan; 19(1):80-7. PubMed ID: 8276371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.